Dr. Clive Ward-Able is the Medical & Scientific Affairs Consultant of NeonMind Biosciences, a company exploring psilocybin as an alternative approach to weight loss and appetite suppression. He shares his insights on the potential of psychedelics in the treatment of obesity, the current trials underway, and what the future may hold.
Dr. Clive Ward-Able is a physician and a pharmacist who has worked in the pharmaceutical industry for over 28 years with 21 of those at the executive level. He has worked in large and small pharmaceutical and biotechnology companies in Canada, the U.S., UK, Switzerland, and South Africa in the departments of R&D, medical, marketing, and sales. He is currently a member of the Board of Directors for Clinical Trials Ontario and has been a member of the Medical & Scientific Advisory Committee of Innovative Medicines Canada.